LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer

被引:0
作者
Yan Ma
Yang Di
Qiuyue Li
Qilin Zhan
Xiaomeng He
Shanshan Liu
Heng Zou
Christopher Corpe
Litian Chen
Jin Wang
机构
[1] Fudan University,Shanghai Public Health Clinical Center
[2] Fudan University,Department of Pancreatic Surgery, Huashan Hospital
[3] King’s College London,Department of Hepatobiliary Surgery
[4] Nutritional Science Department,undefined
[5] Shanghai Jiaotong University School of Medicine Xinhua Hospital,undefined
来源
Discover Oncology | / 13卷
关键词
Pancreatic cancer; lncRNA; Metastasis; EMT; TGF-β/Smad; HIF-1α;
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic cancer is the leading cause of cancer-related mortality because of tumor metastasis. Activation of the epithelial-to-mesenchymal transition (EMT) pathway has been confirmed to be an important driver of pancreatic cancer progression from initiation to metastasis. Long noncoding RNAs (lncRNAs) have been reported to exert essential physiological functions in pancreatic cancer progression by regulating the EMT program. In this review, we have summarized the role of EMT-related lncRNAs in human pancreatic cancer and the potential molecular mechanisms by which lncRNAs can be vital epigenetic regulators of epithelial to mesenchymal transition. Specifically, EMT-activating transcription factors (EMT-TFs) regulate EMT via TGF-β/Smad, Wnt/β-catenin, and JAK/STAT pathways. In addition, the interaction between lncRNAs and HIF-1α and m6A RNA methylation also have an impact on tumor metastasis and EMT in pancreatic cancer. This review will provide insights into lncRNAs as promising biomarkers for tumor metastasis and potential therapeutic strategies for pancreatic cancer.
引用
收藏
相关论文
共 121 条
  • [31] Cao J(2018)LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1 Gene 670 114-26
  • [32] Ma F(2020)Long non-coding RNA LINC01420 contributes to pancreatic cancer progression through targeting KRAS Proto-oncogene Dig Dis Sci 65 1042-207
  • [33] Quinn JJ(2020)LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway Cancer Cell Int 20 296-271
  • [34] Chang HY(2017)Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer Mol Cancer 16 169-104
  • [35] Chen J(2016)LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern Cancer Discov 6 784-783
  • [36] Ju C(2019)The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing Mol Carcinog 58 196-2487
  • [37] Kopp F(2019)KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation Cell Death Dis 10 373-8639
  • [38] Mendell JT(2020)Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer Cell Death Dis 11 155-1030
  • [39] Chen W(2019)The interplay between m6A RNA methylation and noncoding RNA in cancer J Hematol Oncol 12 121-7301
  • [40] Loewen G(2021)LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification J Exp Clin Cancer Res 40 52-646